Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J COLEBATCH

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal for Immunotherapy of Cancer|June 10, 2022
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapyGrace Heloise Attrill, Carina N Owen, Tasnia Ahmed, et al.
The Journal of Pathology|April 4, 2017
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumoursAidan Flynn, Trisha Dwight, Diana Benn, et al.
The Journal of Investigative Dermatology|February 18, 2019
Molecular Genomic Profiling of Melanocytic NeviAndrew J Colebatch, Peter Ferguson, Felicity Newell, et al.
Cancer Immunology Research|September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous MelanomasJarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
JAMA Surgery|February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III MelanomaIrene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.
Cancer Research|December 3, 2015
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell CarcinomasStephen Q Wong, Kelly Waldeck, Ismael A Vergara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology GroupMichael R Sargen, Raymond L Barnhill, David E Elder, et al.
Cancer Discovery|September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma SubtypesFelicity Newell, Peter A Johansson, James S Wilmott, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|June 10, 2022
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapyGrace Heloise Attrill, Carina N Owen, Tasnia Ahmed, et al.
The Journal of Pathology|April 4, 2017
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumoursAidan Flynn, Trisha Dwight, Diana Benn, et al.
The Journal of Investigative Dermatology|February 18, 2019
Molecular Genomic Profiling of Melanocytic NeviAndrew J Colebatch, Peter Ferguson, Felicity Newell, et al.
Cancer Immunology Research|September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous MelanomasJarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
JAMA Surgery|February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III MelanomaIrene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.
Cancer Research|December 3, 2015
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell CarcinomasStephen Q Wong, Kelly Waldeck, Ismael A Vergara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology GroupMichael R Sargen, Raymond L Barnhill, David E Elder, et al.
Cancer Discovery|September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma SubtypesFelicity Newell, Peter A Johansson, James S Wilmott, et al.
Pageof 9